Naftopidil vs silodosin (alpha‐blocker)
Urological symptom scores
1 finding from 1 review
- Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 652 participantsLow